TrialBMC cancer2024

Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial.

Lan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.